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Abstract 
 
The dynamics of the formation of siRNA-lipoplexes coated with hyaluronic acid (HA) and the 
parameters influencing their supramolecular organization were studied. The insertion of a HA-
dioleylphosphatidylethanolamine (DOPE) conjugate in the liposome structure as well as subsequent 
complexation with siRNA increased the liposome size. Lipoplexes were around 110 nm at high ± 
charge ratios with a zeta potential around +50 mV and around 230 nm at low ± ratios, with a zeta 
potential that decreased to negative values, reaching −45 mV. The addition of the conjugate did not 
compromise siRNA binding to liposomes, although these nucleic acids induced a displacement of 
part of the HA-DOPE conjugate upon lipoplex formation, as confirmed by capillary electrophoresis. 
Isothermal titration calorimetry, X-ray diffraction studies, and cryo-TEM microscopy demonstrated 
that in addition to electrostatic interactions with siRNA a rearrangement of the lipid bilayers takes 
place, resulting in condensed oligolamellar vesicles. This phenomenon is dependent on the number 
of siRNA molecules and the degree of modification with HA. Finally, the suitable positioning of HA 
on the lipoplex surface and its ability to bind specifically to the CD44 receptors in a concentration-
dependent manner was demonstrated by surface plasmon resonance analysis. 
  
Introduction 
The downregulation of gene expression using small interfering RNA (siRNA) has raised broad 
interest in medical applications. siRNAs are short double-stranded RNA molecules of 19–21 
nucleotides in length that besides being highly efficient and selective offer the possibility of a long-
lasting therapeutic effect for gene-related diseases. One of the strands is called the guide, which is 
complementary to the coding region of the target mRNA, while the other is known as the passenger 
strand. Once in the cytoplasm, the guide strand binds to the target RNA molecule, which promotes 
the enzymatic cleavage of the mRNA and prevents the synthesis of the protein of interest. However, 
these molecules face some impediments to successful application, similarly to other nucleotide-based 
therapeutics such as plasmid DNA and antisense oligonucleotides.(1) As a result of their small size, 
they are rapidly eliminated by the kidneys and show circulating half-lives of seconds to minutes.(2) 
They are also susceptible to degradation by nucleases in the plasma. Within the tissues, they do not 
cross cell membranes readily because of their negative charge, hydrophilicity, and molecular size. 
Also, siRNAs are taken up by most mammalian cells in a way that does not preserve their activity.(3) 
Therefore, the future of this therapeutic approach heavily depends on the development of delivery 
systems able to carry these molecules from their administration site to their intracellular 
pharmacological target.(4) 
Complexes formed by electrostatic interactions between cationic liposomes and siRNA, called 
lipoplexes, are considered to be the most suitable carriers for the intracellular delivery of nucleic 
acids, particularly for siRNA.(5, 6) In addition, they are versatile systems whose surfaces can be 
modified to increase their circulation time and improve their interaction with the target.(7) One of the 
key factors influencing siRNA delivery is the macromolecular shape of the lipoplex.(8, 9) Their final 
structure has a significant impact on particle stability, interaction with biological components, 
cytotoxicity,(9, 10) and intracellular trafficking(11, 12) and will therefore determine their efficiency 
in vitro and in vivo.(13) It is therefore important to consider an accurate and detailed understanding 
of lipoplex structure and physicochemical characteristics. 
Hyaluronic acid (HA) is a glycosaminoglycan polymer composed of disaccharide units of N-
acetylglucosamine and d-glucuronic acid linked together through alternating β-1,3 and β-1,4 
glycosidic bonds.(14) It is biocompatible, being the major component of the extracellular matrix. The 
native high-molecular-weight HA is nontoxic and nonimmunogenic.(15) It does not induce an 
expression of genes involved in proliferation or inflammation(16) and counteracts proangiogenic 
effects of the HA oligomers.(17, 18) Surface modification of cationic liposomes with high-molecular-
weight HA can improve their efficacy by mediating active CD44 targeting in tumors and can also 
increase their circulation time because of a possible dysopsonization effect due to the hydrophilic 
coating effect of HA.(19-22) 
In this study, we describe the design and physicochemical characterization of novel HA-lipoplexes 
entrapping siRNA. The lipoplex composition is based on cationic lipid 2-(2,3-
didodecyloxypropyl)hydroxyethyl] ammonium bromide (DE), which has shown promising 
transfection efficiency in different cell lines compared to the cationic lipids currently available on the 
market.(23) To achieve the targeting of CD44 receptors, lipoplexes were surface-coated using a 
conjugate of HA and l-α-dioleylphosphatidylethanolamine (DOPE).(24) In previous studies, the 
modification of lipoplexes with the HA-DOPE conjugate demonstrated increased transfection of 
CD44-expressing cells using plasmid DNA(18, 25) and siRNA.(24) The supramolecular organization 
and formation of these lipoplexes, however, remained an open question. Here, a study of the 
formation of these nanocarriers and the aspects influencing the organization of the lipid bilayers was 
performed using a combination of dynamic light scattering, capillary electrophoresis, cryo-TEM 
microscopy, surface plasmon resonance, and small-angle X-ray scattering techniques. 
  
Experimental Section 
Materials 
Cationic lipid [2-(2,3-didodecyloxypropyl)hydroxyethyl] ammonium bromide (DE) was synthesized 
as described previously.(23) l-α-Dioleylphosphatidylethanolamine (DOPE) and 
phosphatidylethanolamine conjugated to rhodamine (PE-rhodamine) were purchased from Avanti 
Polar Lipids distributed by Sigma-Aldrich (Saint Quentin Fallavier, France). High-molecular-weight 
HA (sodium salt, 1600 kDa, purity of 95%) was provided by Acros Organics (Geel, Belgium). SiRNA 
(19 bp) was purchased from Eurogentec (Angers, France) and diluted in RNase-free water before use. 
The HA-DOPE conjugate was synthesized as described previously.(25) In the following text, water 
refers to ultrapurified Milli-Q water (Millipore, France) with a resistivity of ≥18 MΩ·cm. 
 
Liposome and Lipoplex Preparation 
Liposomes of DOPE/DE in a 1:1 w/w ratio (equivalent to a molar ratio of 0.78:1) were prepared in 
water by the ethanol injection method.(24, 26) Separate solutions of DE and DOPE, stored in 
chloroform under nitrogen at −20 °C, were dried under pressure in a rotary evaporator. The dried 
lipids were then dissolved in absolute ethanol at a concentration of 10 mg/mL. For liposome 
preparation, 0.06 to 0.9 mL of the ethanolic lipid solution was rapidly injected into RNase-free water 
under magnetic stirring. HA-liposomes were prepared by diluting an aqueous stock solution of the 
HA-DOPE conjugate (1 mg/mL) to different concentrations in RNase free water before injection. 
Each conjugate has 3 µg of DOPE/mg of HA. The HA-DOPE content of liposomes is expressed as 
the mass ratio of HA-DOPE to other lipids (DE + DOPE) (10% refers to 1:10 w/w). Liposome 
suspensions were dialyzed against 1 L of Milli-Q water overnight in Spectra/Por CE dialysis tubes 
with a molecular weight cutoff of 50 kDa (Spectrum Laboratories, Breda, Netherlands) to eliminate 
ethanol. Lipoplexes were then prepared at different charge ratios (± ratios) by adding 1 volume of the 
3 mM liposome suspension to 2 volumes of siRNA solution at different concentrations (0.11, 0.16, 
0.22, 0.44, 5.52, 7.36, 11.05, and 22.10 µM for ± ratios of 200, 134, 100, 50, 4, 3, 2, and 1) in an 
Eppendorf tube and gently homogenizing by pipetting up and down. Suspensions of 15 µL – 2.5 mL 
of lipoplexes were usually prepared and incubated for 1 h at room temperature before use. 
 
Hydrodynamic Diameter and Zeta Potential Measurements 
The mean hydrodynamic diameter, polydispersity index (PdI), and zeta potential were determined 
with a Zetasizer Nano Zs (Malvern Instruments Ltd., Malvern, U.K.). Before each measurement, 
liposomes and lipoplexes were diluted in 1 mM NaCl. Measurements were carried out in triplicate at 
25 °C for at least three independent preparations. 
Colloidal Stability of Lipoplexes in Isotonic Media 
Noncoated, 10% HA-liposomes and HA-lipoplexes at various charge ratios were prepared as 
described above and diluted down to 66 µg/mL of lipids with 0.9% w/v NaCl or 5% w/v glucose. 
Changes in hydrodynamic diameter upon dilution were monitored at 25 °C. The accuracy of 
measurements was verified by mixing each suspension thoroughly before each measurement. All 
experiments were performed at least in duplicate. 
 
Lipoplex siRNA Content 
siRNAs were labeled at the 5′-end with γ-33P-ATP (PerkinElmer Life Sciences, Courtaboeuf, France) 
as catalyzed by T4 polynucleotide kinase (New England Biolabs, Frankfurt am Main, Germany) 
according to the manufacturer’s protocol. Lipoplexes were prepared with radiolabeled siRNA at 
various ± ratios (2–134) from noncoated or 10% HA-liposomes. Suspensions were placed in the upper 
chamber of Amicon Ultra 0.5 mL filters (cutoff value 100 kDa; Millipore). After adding 200 µL of 
RNase-free water, samples were centrifuged (14 000g, 30 min, 4 °C). This procedure was repeated 
five times. Binding efficiencies were determined by comparing the sum of the specific radioactivity 
of the washings to the radioactivity of the siRNA solution used for the lipoplex preparation. 
Experiments were performed in triplicate. 
 
Capillary Electrophoresis 
A Beckman P/ACE System 5500 was used with an uncoated fused silica capillary of 57 cm effective 
length and an internal diameter of 75 µm. Electrophoresis conditions to analyze the HA-DOPE 
conjugate were derived from Grimshaw et al.(27) for the assay of HA. The capillary was first 
conditioned by four successive rinsing steps of 5 min each with water, 1 M NaOH, 0.1 M NaOH, and 
back to water. Before each analysis, the capillary was washed at 20 psi with water for 2 min and 0.1 
M NaOH for 3 min and finally equilibrated with the background electrolyte for 5 min. The separation 
buffer was 65 mM sodium tetraborate containing 20 mM sodium dodecyl sulfate (SDS) at pH 9.0. 
Sample injection was carried out at 0.5 psi for 5 s. All samples were adjusted to a concentration of 1 
mg/mL of HA or HA-DOPE by evaporation under vacuum using an Eppendorf Concentrator at 30 
°C. This step was validated after verification by dynamic light scattering that no modification of the 
diameter and zeta potential occurred during the concentration. The free fraction of conjugate was 
determined using a HA-DOPE 1 mg/mL solution as an internal standard. Samples containing 1 
mg/mL HA-DOPE + HA-DOPE solutions at 0.25, 0.5, 1, and 2.5 mg/mL were analyzed, and the peak 
areas obtained were used to form calibration curves. The peak areas found by extrapolation of the 
sample curves to the point [HA-DOPE] = 0 were used in the HA-DOPE calibration curve to determine 
the free amount of conjugate. The detection wavelength was 200 nm, and the voltage applied was 
+25 kV. The capillary was maintained at 25 °C during electrophoresis. Experiments were performed 
at least in duplicate. 
 
Isothermal Titration Calorimetry 
The thermodynamics of the interaction between siRNA and the cationic liposomes, coated or not with 
HA, was evaluated by isothermal titration calorimetry (ITC) (Microcal Inc., USA). Aliquots of 10 µL 
of aqueous siRNA solution (19.7 µM) placed in a 283 µL syringe were used to titrate the aqueous 
suspension of liposomes (98 µM total lipids) in the calorimetric sample cell accurately thermostated 
at 25 °C. The agitation speed was 307 rpm, and the interval between injections was 500 s. The titration 
background consisted of injecting the siRNA solution in Milli-Q water. The heats of dilution were 
insignificant compared to the binding interaction heats. 
 
Cryo-transmission Electron Microscopy 
HA-liposomes (10%) and HA-lipoplexes containing siRNA at ± ratios of 2 and 134 were observed 
using cryo-transmission electron microscopy (cryo-TEM). The preparation of liposome samples was 
performed as follows. A concentrated liposome aqueous suspension (4 µL) was placed on Quantifoil 
R2/2 grids (Quantifoil, Germany). The samples were cryofixed in liquid ethane (−180 °C) using the 
Leica EMGP (Leica, Austria). For lipoplex samples, grids were pretreated with 1 mM CaCl2 for 1 
min. Grids were transferred using a cryo-holder (626 DH Gatan) for observation on a Tecnai F20 
electron microscope (FEI, USA). Images were recorded under low-electron-dose conditions at 200 
kV on a Gatan Ultrascan 4000 camera with Digital Micrograph (Gatan, USA) version 1.83.842. Doses 
were previously quantified using a faraday cup. 
 
Small-Angle X-ray Scattering (SAXS) 
Suspensions of liposomes and lipoplexes were loaded into quartz capillaries (diameter 1.5 mm, Glas-
Müller, Berlin, Germany). The top of the capillaries was sealed with a drop of paraffin to prevent 
water evaporation. Small-angle X-ray scattering experiments were performed on the SWING 
beamline at the SOLEIL synchrotron. The energy was set to 11 keV. The scattering intensity was 
reported as a function of scattering vector q = 4π/λ sin θ, where 2θ is the scattering angle and λ is the 
wavelength of the incident beam. Calibration of the q range (0.008–0.4 Å–1) was carried out with 
silver behenate as the standard. Data were collected with a two-dimensional CCD detector. The 
acquisition time was 50 s. Intensity values were normalized to account for the beam intensity, 
acquisition time, and sample transmission. Each scattering pattern was then integrated circularly to 
yield the intensity as a function of q. The scattering intensity from a capillary filled with water was 
subtracted from the sample scattering curves. 
 
HA-Lipoplex CD44 Receptor Affinity by Surface Plasmon Resonance Spectroscopy 
The interaction of noncoated and HA-lipoplexes with CD44 receptors was monitored by surface 
plasmon resonance (SPR) spectroscopy using a BIAcore T100 (GE Healthcare Life Sciences, Vélizy, 
France) instrument. Human recombinant CD44-Fc receptors were immobilized on a 
carboxymethylated dextran sensor chip (series S CM3, GE Healthcare) using amine coupling. 
Carboxylic groups were activated by a mixture of EDC/NHS for 7 min at 10 µL/min followed by an 
injection of 17 µg/mL CD44-Fc in a 10 mM acetate buffer at pH 4.4 for 5 min at 10 µL/min. The 
remaining groups were blocked by an injection of ethanolamine. A flow channel blocked by 
ethanolamine was used as a reference surface. The specific interaction of HA-lipoplexes (at 
concentrations 0.3, 0.6, 1.2, 2.4, and 4.8 µM lipids) with the immobilized CD44-Fc was assessed. All 
experiments were conducted at a flow rate of 50 µL/min in 150 mM NaCl with a contact time of 360 
s. The surface was washed for 640 s and regenerated with a 34 mM octyl-glucoside solution for 30 s 
at 50 µL/min and 10 mM NaOH for 30 s at 100 µL/min after each sample analysis. Free 1600 kDa 
HA solution was systematically passed through the channel to verify the integrity of the CD44-Fc 
receptors. The analyses were performed in triplicate using BIAcore T100 evaluation software, version 
2.0.2 (GE Healthcare). 
  
Results and Discussion 
In this study, siRNA-loaded lipoplexes coated with hyaluronic acid (HA) were formulated and 
characterized to investigate their structure and affinity for CD44 receptors, with a view to developing 
effective gene-silencing nanomedicines targeting this receptor, a key marker of cancer metastasis. 
We have chosen to coat the lipoplexes with a large-molecular-weight HA since we have already 
shown that an increased internalization of siRNA binding of these HA-lipoplexes was obtained in 
CD44-expressing cells.(24) SiRNA HA-lipoplexes were characterized here using a combination of a 
light-scattering technique, radioactive labeling, diameter and surface charge analyses, capillary 
electrophoresis, cryo-TEM microscopy, SAXS, and surface plasmon resonance. 
To insert HA into the lipoplex structure, a HA-DOPE conjugate was prepared by a condensation 
reaction between the carboxylic residues of HA and amino groups of DOPE lipids. DOPE within the 
conjugate was used as a lipid anchor. The absence of free DOPE on the conjugate was confirmed by 
thin-layer chromatography, and the amount of lipids was quantified as 1.1 ± 0.5% w/w using Stewart 
assay.(28) Noncoated liposomes obtained by the ethanol injection method were 88 ± 8 nm in size 
(Figure 1). The effect of HA-DOPE insertion on the diameter and zeta potential was studied by adding 
0, 5, 10, and 15% (w/w) conjugate when preparing the liposomes. A gradual increase in diameter 
with increasing HA-DOPE content was observed (Figure 1), indicating the insertion of HA in the 
liposome structure. Liposomes with 15% HA-DOPE reached diameters of 142 ± 19 nm, and larger 
amounts of conjugate resulted in the formation of agglomerates, probably due to a bridging interaction 
between HA molecules on the lipoplex surface. Noncoated and HA-liposomes maintained their size 
for at least 4 months when stored at 4 °C. The absence of vesicles or micelles formed by the HA-
DOPE conjugate itself was confirmed using light-scattering measurements. Zeta potential values 
were positive in the range of +55 to +30 mV for liposome preparations due to the presence of amino 
groups of cationic lipid DE, gradually decreasing with increasing amounts of HA-DOPE conjugate, 
again confirming the presence of HA on the surface of the particles. 
 
 
Figure 1. Mean hydrodynamic diameter and zeta potential of cationic liposomes prepared without or 
with 5, 10, or 15% HA-DOPE (n = 3). Data = mean ± SD. 
HA-DOPE (10%) was chosen for the preparation of lipoplexes. This amount was previously shown 
to be an optimal amount for the transfection of MDA-MB231 and A549 cancer cells expressing 
CD44.(18, 25) The complexation of liposomes with siRNA at low concentrations (± ratios of 200, 
100, and 50) resulted in lipoplexes with diameters comparable to those of liposomes, around 90 nm 
for the noncoated and 120 nm for the HA-liposomes (Figure 2). When larger amounts of siRNA were 
complexed (at ratios 4, 3, 2, and 1), the diameters of noncoated and HA-liposome increased to around 
140 and 230 nm, respectively (Figure 2). The size distribution in these samples was quite large. The 
PdI of HA-liposomes and HA-lipoplexes was, however, below 0.23 for all lipoplex formulations. The 
zeta potential measurements of lipoplexes clearly confirmed differences in the degree of surface 
modification. Between ratios of 200 and 50, all formulations were positively charged, with a slight 
reduction of the zeta potential being observed for the HA-lipoplexes, when compared to those of the 
noncoated lipoplexes (Figure 2). At lower ± ratios, a decrease in zeta potential was observed for all 
lipoplexes formulations (Figure 2). The shift from positive to negative surface charges for the 
noncoated liposomes was observed between ± ratios of 2 and 1, which demonstrated that the 
neutralization of surface charges occurs when there is an equimolarity of positive and negative 
charges on the lipoplex structure. Interestingly, this turning point from positive to negative surface 
charge is shifted for the HA-lipoplexes. In this case, the number of siRNA molecules needed to 
achieve neutrality is smaller, confirming the presence of the negatively charged HA molecules on the 
liposome structure. The effect of the dilution of HA-liposomes/lipoplexes in physiological media was 
studied. Both HA-liposomes and HA-lipoplexes (± ratio of 2) maintained their size and surface charge 
when diluted in 0.9% w/v NaCl and 5% w/v glucose (Figure S1). These data demonstrate previous 
results confirming that the HA-lipoplexes are rather stable in different media even in the presence of 
serum.(18) 
 
 
Figure 2. Mean hydrodynamic diameter (bars) and zeta potential (lines) of cationic liposomes and 
lipoplexes prepared without (gray) or with 10% HA-DOPE (black) at different ± ratios (200, 100, 50, 
4, 3, 2, and 1). Data = mean ± SD. 
The effect of liposome modification by HA-DOPE on the association rate between liposomes and 
siRNA to form lipoplexes was measured after the radioactive labeling of siRNA. Interestingly, the 
presence of HA on the liposome surface did not compromise the association to the siRNA molecules 
(Figure 3A,B). More than 90% of the added siRNA was bound to the liposomes for ± ratios of as low 
as 2 (Figure 3 A) while the amount of siRNA bound to lipoplexes increased progressively, reaching 
approximately 300 µg/mg of lipids (Figure 3B). The maximum entrapment efficiency of nucleotides 
is commonly described for lipoplex-like structures.(29-32) The strong interactions between the 
negative phosphate groups on nucleotides and the positive charges of amino groups on cationic lipids 
lead to such a high association efficiency.(33-35) However, this binding decreased to 60–70% at a ± 
ratio of 1, indicating a possible saturation of the available positively charged binding sites on the 
liposomes occurring between ± ratios of 1 and 2 (Figure 3 A). Lipoplexes at ± ratio 2 (negative zeta 
potential) were chosen for further experiments while in some cases and to understand lipoplex 
formation higher ± ratios were used (positively charged close to the initial liposome characteristics). 
Noncoated liposomes and their respective lipoplexes were used for comparison. 
 Figure 3. (A) siRNA association efficiency (%) to liposomes and (B) siRNA loading (µgsiRNA/mglipids) 
of lipoplexes as a function of the ± ratio and the HA-DOPE content of the parent liposomes. Data = 
mean ± SD. 
The heat exchanged during the interaction between DE/DOPE liposomes and siRNA was analyzed 
by isothermal titration calorimetry. Figure 4 shows the cumulative heat curves plotted against the 
siRNA/DE molar ratios for each liposome type, with the raw ITC data processed and fitted to obtain 
the thermodynamic parameters of the interaction. A first negative enthalpy change occurs in the 
interaction of both noncoated and HA-liposomes with siRNA molecules. This exothermic reaction 
represents the interaction between DE lipid molecules and siRNA, and the fact that it occurs almost 
identically for both samples confirms the previous observation that the presence of HA does not 
prevent the interaction between siRNA and DE. 
 
Figure 4. Cumulative heat curves and thermodynamic parameters obtained from the calorimetric 
titration of siRNA solution at 19.7 µM (10 µL/injection) into noncoated or an HA-liposome 
suspension at 98 µM. 
The exothermic binding of siRNA molecules to liposomes was observed until all of the binding sites 
in the liposomes were occupied at a ± ratio of 1, corresponding to a molar ratio of siRNA/DE of 
0.025, as evidenced by radioactivity measurements. The monotonous decrease in the amount of heat 
produced after each injection suggested that there is only one type of binding site in the 
liposomes.(36) These observations are in agreement with reports from the literature on 
thermodynamic studies of DNA lipoplexes containing DOPE in their composition.(37-39) They are 
related to the fact that DOPE amine groups (pKa = 9.5) are unprotonated before binding due to the 
high surface pH usually measured in cationic liposomes (around 11) whereas proton uptake occurs 
upon lipoplex formation.(39) Since DOPE protonation is an exothermic process, it is suggested, as 
shown in DOTAP/DOPE-containing lipoplex,(37) that changes in the protonation state of DOPE 
account for the exothermic nature of complex formation with these lipids. 
An assessment of the HA-DOPE conjugate purity and a determination of the HA-DOPE fraction 
bound to liposomes and lipoplexes were carried out by capillary electrophoresis. The HA-DOPE 
migration time was 5 min, and the electrophoretic profile of the conjugate did not display the 
characteristic peak of unconjugated HA expected at 8 min, demonstrating the absence of free HA in 
the conjugate (Figure S2). Large amounts of the HA-DOPE conjugate added to the formulations were 
found to be associated with the liposomes and lipoplexes at a ± ratio of 134 (66 and 78%, respectively) 
(Table 1). A decrease in HA-conjugate associated with lipoplexes at a ± ratio of 2, reaching 36%, was 
observed (Table 1). A similar phenomenon was previously observed for lipoplexes prepared using 
plasmid DNA.(18) As discussed above, the association of nucleotide molecules to cationic lipids is 
known to be strong and commonly yields stable lipoplexes with high association efficiencies.(33, 40) 
We hypothesized that the large and concentrated number of negative charges on the siRNA molecules 
leads to a competition with the negative charges of HA for interaction with the positive charges of 
cationic lipids, causing some displacement of HA-DOPE conjugate molecules from the liposome 
structure. This implies that HA-DOPE insertion into the lipoplexes occurs not only through the DOPE 
moiety but also via electrostatic interactions. 
 
 
Table 1. HA-DOPE Conjugate Association Efficiency to Liposomes and Lipoplexes Prepared at ± 
Ratios of 134 and 2 
 
Preparation % HA-DOPE associated 
liposomes DE/DOPE/DOPE-HA 66.5 ± 3.9 
lipoplexes DE/DOPE/DOPE-HA/siRNA (±134) 78.8 ± 9.8 
lipoplexes DE/DOPE/DOPE-HA/siRNA (±2) 36.3 ± 3.9 
 
Cryo-TEM images of cationic liposomes revealed the coexistence of spherical unilamellar and 
oligolamellar vesicles (Figure 5). The diameters observed were in the range of the hydrodynamic 
diameters measured, with some degree of heterogeneity correlated to a measured polydispersity index 
of 0.22. A modification of this morphology was observed after the addition of siRNA to liposomes. 
At a ± ratio of 134, the lipoplex shape was less spherical and homogeneous than the liposome shape 
(Figure 5A,B). At a ± ratio of 2, the structural changes were even more pronounced (Figure 5C). All 
liposomes/lipoplexes appeared as dense multilamellar structures, suggesting a reorganization of lipids 
in the presence of siRNA. In particular, the intralamellar distances appeared to be smaller than those 
observed on the parent oligolamellar liposomes. These observed lipoplexes can be compared to the 
well-known “sandwich” structures,(29, 41-43) suggesting the presence of electron-dense siRNA 
molecules intercalated between the cationic lipidic membranes.(6) The deformation and 
rearrangement of the liposomal membranes are a result of the strong electrostatic interaction between 
cationic lipid headgroups and siRNA phosphate groups.(29, 43) This structural modification is 
beneficial as far as siRNA stability is concerned. Indeed, the bilayer packing around each other 
promotes the protection of the siRNA molecules from degradation better than an exclusive surface 
association, in which they would be more susceptible to degradation by serum nucleases.(29, 44) 
 Figure 5. Cryo-TEM images of (A) HA-liposomes, (B) HA-lipoplexes at a ± ratio of 134, and (C) 
HA-lipoplexes at a ± ratio of 2. Scale bars = 200 nm. 
Evidence of the siRNA localization was provided by cryo-TEM analysis. When the particles were 
submitted to the electron beam for image acquisition, the formation of “bubbles” was observed 
(Figure 6). Micrographs were recorded at approximately 3 electrons/Å2 per exposure, with intervals 
of 10 s between exposures. Bubbling started on the second exposure with the appearance of several 
small bubbles, which merge to give fewer and larger ones later in the exposure sequence. This 
occurred for all of the ±2 lipoplexes, a few of the ±134 lipoplexes, and none of the liposomes 
structures, indicating that this event occurred only when siRNA was present. The pattern of bubble 
formation inside the vesicles is shown in Figure 6. We hypothesize that bubbling is due to the 
degradation of water molecules associated with the siRNAs, since the pattern of bubble formation 
observed is characteristic of the formation of hydrogen gas upon electron radiation of samples.(45, 
46) Bubblegram imaging has been previously used for the structural localization of proteins in 
vitrified specimens and DNA virus internal structure investigation.(47-49) We report here for the first 
time bubble formation evidencing siRNA localization within the lipoplexes. The uniform localization 
of the bubbles confirms the distribution of siRNA molecules within the lipoplexes, intercalated with 
the lipid membranes. 
 
Figure 6. Cryo-TEM images of HA-lipoplexes at a ± ratio of 2 after exposure to approximately (A) 
3, (B) 6, (C) 9, and (D) 12 electrons/Å2, evidencing the formation of bubbles where siRNA is present. 
Scale bars = 200 nm. 
The structure of noncoated and HA-liposomes with 5, 10, and 15% HA-DOPE was further 
investigated using synchrotron small-angle X-ray scattering (SAXS). The pattern of the noncoated 
liposome suspension exhibits a broad bump, consistent with the bilayer form factor of unilamellar 
vesicles(50) (Figure 7A). The SAXS curves of HA-liposomes reveal the gradual increase in the 
diffraction peak intensities when increasing amounts of HA were added to the formulation, indicating 
the formation of increasingly dense multilamellar structures.(51) This interestingly highlighted 
liposome organization in the presence of hyaluronic acid. In our method of liposome preparation, HA 
is present at the moment the vesicles are formed. We may therefore assume that a portion of the 
multiple DOPE units bound to each HA molecule intercalates within the DOPE and DE bilayers upon 
liposome preparation.(25, 52) The correlation between regularly spaced bilayers gives rise to a Bragg 
peak. A tiny peak is barely detected in the 5% HA-DOPE liposome curve. As the HA-DOPE content 
in the formulation increases, the intensity of the Bragg peak increases while its full width at half-
maximum decreases, indicative of a greater number of bilayers in vesicles and/or of multilamellar 
vesicles in the preparation. However, the lack of a second-order peak up to 15% HA-DOPE suggests 
weakly ordered stacks of bilayers. The characteristic repeat spacing (d spacing), corresponding to the 
sum of the bilayer thickness and water thickness, is deduced from the position of the Bragg peak (d 
= 2π/q). A small increase in d is observed, from d = 60.4 Å (q = 0.104 Å–1) to d = 63.4 Å (q = 0.099 
Å–1) when the HA-DOPE amount increases from 10 to 15%, likely reflecting a higher hydration of 
the lamellar phase and a more important steric repulsion. The structural differences between the 
noncoated and HA-liposomes could be tentatively related to the differences in net surface charge 
between bilayers. Indeed, a net surface charge induces electrostatic repulsion between bilayers so that 
they can swell in excess water. The spontaneous formation of unilamellar vesicles in the DOPE/DE 
system may be explained by electrostatic repulsion overwhelming van der Waals attraction between 
bilayers. The addition of HA-DOPE leads to a progressive decrease in the bilayer surface charge and 
consequently in repulsive forces between bilayers so that a multilamellar structure is formed. 
Furthermore, negatively charged HA could bridge positively charged lipid bilayers. 
 
Figure 7. (A) Small-angle X-ray diffraction patterns recorded at room temperature for cationic 
liposomes, either noncoated or prepared with 5, 10, or 15% HA-DOPE. The gradual increase in the 
diffraction peak intensity suggests a gradual reorganization of the unilamellar liposomes into 
oligolamellar structures (a.u = arbitrary units). (B) Small-angle X-ray diffraction patterns recorded at 
room temperature for noncoated and HA-lipoplexes prepared at ± ratios of 2 and 20. The well-defined 
Bragg peaks suggest the formation of DOPE/DE-siRNA or HA-DOPE/DE-siRNA complexes, with 
siRNA confined between regularly stacked lipid bilayers. 
As previously reported, siRNA interacts with cationic DOPE/DE liposomes. The SAXS patterns of 
noncoated lipoplexes evidence the reorganization of unilamellar liposomes into oligolamellar vesicles 
in the presence of siRNA at low ± ratios. Indeed, at a ±20 ratio, only a small correlation peak appears 
at q = 0.116 Å–1 (d = 54.1 Å), suggesting that unilamellar liposomes with siRNA absorbed on their 
surfaces coexist with a few oligolamellar vesicles. In contrast, at a ± ratio of 2, a sharp Bragg peak at 
q = 0.112 Å–1 and a faint second order, indicative of a lamellar phase with a d spacing of 56.1 Å, are 
observed (Figure 7B). When HA-liposomes are used for the preparation of lipoplexes (± 2 ratio), a 
sharper Bragg peak at q = 0.102 Å–1 and a stronger second order are observed, reflecting a more 
ordered lamellar phase with a d spacing of 61.4 Å. This suggests that siRNA is confined between 
ordered lipid bilayers. Similar behavior was observed for HA-lipoplexes. These findings are 
consistent with the existing schematic models of lipoplex formation(42, 53) and with the evolution 
of nanoparticle size upon complexation. This gradual modification of vesicle morphology after 
interaction between siRNA and cationic liposomes measured by SAXS was confirmed by cryo-TEM 
microscopy as shown above. 
The binding affinity to CD44 receptors of noncoated and 10% HA-lipoplexes prepared at a ± ratio of 
2 was determined using surface plasmon resonance (SPR). CD44-Fc was immobilized in a stable and 
suitably oriented manner on the surface, as confirmed by an analysis of the interaction of the receptors 
with HA solution. HA did not show any binding when exposed to the reference surface, indicating 
that binding to the receptors was specific. The immobilization protocol allowed the binding of 100–
150 RU, corresponding to 0.1–0.15 ng·mm–2 of CD44-Fc per channel. Sensorgrams obtained by the 
interaction of different concentrations of HA-lipoplexes and plain lipoplexes with the CD44-Fc-
immobilized sensor chip were used to analyze the binding affinity. Representative sensorgrams 
obtained in this experiment are shown in Figure 8. Signals of HA-lipoplexes were normalized using 
signals from nonmodified lipoplexes at the same concentrations to eliminate nonspecific interaction 
signals. Considering the molecular weight of the CD44-Fc used for these experiments (48.6 kDa), we 
estimate that 12.3–18.5 receptors were immobilized per nm2. The difference between the obtained 
signals reveals a concentration-dependent and preferential affinity of HA-lipoplexes compared to the 
nonmodified lipoplexes (Figure 8), thereby confirming both the suitable positioning of HA on the 
lipoplex surface and the HA ability to bind specifically to the CD44 receptors. The CD44-Fc 
immobilization combined with the surface rinsing protocol after HA interactions represents a 
significant improvement in the SPR techniques to analyze HA binding to CD44. First, the low sensor 
surface capacity was suitable for the interaction studies.(54) Previously reported SPR data on the HA-
CD44 interaction are based on interaction studies on highly loaded sensor surfaces,(55-57) which 
complicates data analysis and may misrepresent the interaction between HA and CD44.(58) Second, 
the rinsing protocol promoted the detachment of HA-lipoplexes from the CD44-Fc surface after each 
analysis without damaging the receptors. This was an experimental hurdle due to the multivalent 
aspect of this interaction and required many optimization steps. Little or no desorption upon rinsing 
high-molecular-weight HA molecules after interaction with its receptors has been described until 
now.(58, 59) The kinetic model that best fit the data obtained was the heterogeneity model with four 
independent binding sites. Nevertheless, we believe that due to the presence of multiple binding sites 
on each HA, the complexity of the HA-lipoplex structure, and rebinding events during dissociation, 
a precise kinetic characterization of the HA-lipoplex–CD44 interaction cannot be properly resolved. 
 
Figure 8. SPR sensorgrams obtained by the injection of 10% HA-lipoplexes ± ratio 2 on CD44-Fc-
immobilized sensor chips. Samples were diluted in 150 mM NaCl to 4.8, 2.4, 1.2, 0.6, and 0.3 µM 
lipids. Signals of HA-lipoplexes were normalized using signals from nonmodified lipoplexes at the 
same concentrations to eliminate nonspecific interaction signals. 
  
Conclusions 
Lipoplexes are promising siRNA delivery systems that have been studied for gene expression 
inhibition. An accurate and detailed comprehension of their structure and physicochemical 
characteristics is crucial because of their influence in vitro and in vivo on the efficiency of these 
nanocarriers. Here, we developed and investigated in detail the structure of novel HA-lipoplexes for 
the delivery of siRNA. With the combination of radioactive labeling, diameter and surface charge 
analyses, capillary electrophoresis, cryo-TEM microscopy, SAXS, and surface plasmon resonance, 
the influence of the components of the formulation on lipoplex morphology was determined. We 
demonstrated an improvement in the SPR method for CD44-HA binding studies and described for 
the first time evidence of siRNA localization using cryo-TEM microscopy. We provided additional 
information showing the interest of lipoplexes containing the HA-DOPE conjugate, which associated 
large amounts of siRNA, improved stability in physiological media, and provided increasing affinity 
to CD44 receptors with increasing HA content. These outputs contribute to the improvement of the 
siRNA lipoplex development and characterization methods and provide future research directions for 
the characterization of these nanocarriers for successful use in gene delivery. 
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